Holen Sie sich die Stockscreener-App
8.36
3.34%
0.27
Finanzdaten der Kalvista Pharmaceuticals Inc-Aktie (KALV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.45%
33.15
|
29.75 | 29.09 | 31.73 | 26.95 |
| Operating Income/Loss |
11.45%
-33.15
|
-29.75 | -29.09 | -31.73 | -26.95 |
| Nonoperating Income/Loss |
96.71%
4.123
|
2.096 | 3.776 | 5.423 | 5.642 |
| Income/Loss From Continuing Operations Before Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
| Income/Loss From Continuing Operations After Tax |
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
|
Net Income/Loss
|
4.98%
-29.03
|
-27.65 | -25.32 | -26.30 | -21.30 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
| Diluted Average Shares |
0.46%
34.72
|
34.57 | 34.41 | 2.0805 | 28.28 |
| Basic Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
| Diluted Earnings Per Share |
5.00%
-0.84
|
-0.80 | -0.74 | -0.75 | -0.75 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):